Hologic, Inc. (BMV:HOLX)

Revenue

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2012 - 2020
Period Ending	Jun 30, 2025	Sep 28, 2024	Sep 30, 2023	Sep 24, 2022	Sep 25, 2021	2012 - 2020
Diagnostics Revenue	1.82B	1.78B	Log In	Log In	Log In	Upgrade
Breast Health Revenue	1.47B	1.52B	Log In	Log In	Log In	Upgrade
GYN Surgical Revenue	663.70M	641.30M	Log In	Log In	Log In	Upgrade
Skeletal Health Revenue	92.80M	84.10M	Log In	Log In	Log In	Upgrade
Revenue (Other)	-	100.00K	Log In	Log In	Log In	Upgrade
Revenue (Total)	-	4.03B	Log In	Log In	Log In	Upgrade

EBIT

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2012 - 2020
Period Ending	Jun 30, 2025	Sep 28, 2024	Sep 30, 2023	Sep 24, 2022	Sep 25, 2021	2012 - 2020
Diagnostics Operating Income	342.40M	303.10M	Log In	Log In	Log In	Upgrade
Breast Health Operating Income	361.00M	394.50M	Log In	Log In	Log In	Upgrade
GYN Surgical Operating Income	12.00M	185.50M	Log In	Log In	Log In	Upgrade
Skeletal Health Operating Income	-8.00M	-500.00K	Log In	Log In	Log In	Upgrade
Operating Income (Total)	-	882.60M	Log In	Log In	Log In	Upgrade

Capital Expenditures

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2012 - 2020
Period Ending	Jun 30, 2025	Sep 28, 2024	Sep 30, 2023	Sep 24, 2022	Sep 25, 2021	2012 - 2020
Diagnostics Capital Expenditures	85.60M	80.20M	Log In	Log In	Log In	Upgrade
Breast Health Capital Expenditures	21.20M	30.90M	Log In	Log In	Log In	Upgrade
GYN Surgical Capital Expenditures	25.50M	16.60M	Log In	Log In	Log In	Upgrade
Skeletal Health Capital Expenditures	-	1.40M	Log In	Log In	Log In	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai.